Research output per year
Research output per year
Personal profile
Research interests
Pharmacokinetics and pharmacodynamics of anti TB drugs
Inhalation of antimicrobial drugs
Holistic approach of TB care
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Onno Akkerman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Aspergillus After Lung Transplantation: Prophylaxis, Risk Factors, and the Impact on Chronic Lung Allograft Dysfunction
van Gemert, J. P., Fleurke, G. J., Akkerman, O. W., Gan, C. T., Steenhuis, W. N., Kerstjens, H. A. M., Verschuuren, E. A. M. & Postma, D. F., 18-Mar-2025, (E-pub ahead of print) In: Transplant Infectious Disease.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Azithromycin as host-directed therapy for pulmonary tuberculosis - a randomized pilot trial
Dekkers, B. G. J., Kerstjens, H. A. M., Breisnes, H. W., Leeming, D. J., Anthony, R. M., Frijlink, H. W., van der Werf, T. S., Kosterink, J. G. W., Alffenaar, J.-W. C. & Akkerman, O. W., 11-Feb-2025, (E-pub ahead of print) In: The Journal of Infectious Diseases.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Downloads (Pure) -
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis
endTB Study Group, Garcia-Prats, A. J., Garcia-Cremades, M., Cox, V., Kredo, T., Dunbar, R., Schaaf, H. S., Seddon, J. A., Furin, J., Achar, J., Radke, K., Sachs, T., Abubakirov, A., Ahmed, S., Akkerman, O. W., Al Ani, N. A., Amanullah, F., Ahmad, N., Anderson, L. F. & Asfaw, M. & 32 others, , Feb-2025, In: Lancet child & adolescent health. 9, 2, p. 100-111 12 p.Research output: Contribution to journal › Article › Academic › peer-review
1 Citation (Scopus) -
ERS Congress 2024: highlights from the Respiratory Infections Assembly
Jonckheere, L., Papadopoulou, E., Piedepalumbo, F., Akkerman, O. W., Duarte, R. & Premuda, C., Mar-2025, In: ERJ Open Research. 11, 2, 4 p.Research output: Contribution to journal › Editorial › Academic › peer-review
Open AccessFile -
Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study
KOALA study group, van Gemert, A., Luijk, B., Hellemons, M. E., Visser, K. A., Hansen, C., van der Meer, R., Gan, C. T., van der Vaart, H., Akkerman, O., Steenhuis, W. N., Verkleij, M., Heijerman, H. G. M. & Verschuuren, E., Feb-2025, In: JHLT Open. 7, 9 p., 100210.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile
Activities
-
Casus presentatie met verdieping door consulent voor klinische tuberculose
Akkerman, O. (Speaker)
12-Jan-2025Activity: Talk and presentation › Professional or public presentation › Professional
-
Presentation Scholingsdagen Tuberculose coördinator. Diagnostiek van TBC.
Akkerman, O. (Speaker)
25-Jan-2025Activity: Talk and presentation › Professional or public presentation › Professional
-
Presentation Scholingsdagen Tuberculose coordinator. “Work-up pre-immuunsuppressie”.
Akkerman, O. (Speaker)
26-Jan-2025Activity: Talk and presentation › Professional or public presentation › Professional
-
“The Dutch TB centre Beatrixoord”
Akkerman, O. (Speaker)
27-May-2024Activity: Talk and presentation › Professional or public presentation › Professional
-
“Updates on vaccines”
Akkerman, O. (Speaker)
29-Jul-2024Activity: Talk and presentation › Professional or public presentation › Professional
Datasets
-
Data from: Evaluation of whole-genome sequence data analysis approaches for short- and long-read sequencing of Mycobacterium tuberculosis
Peker, N. (Contributor), Schüle, L. (Contributor), Kok, N. (Contributor), Terrazos, M. (Contributor), Neuenschwander, S. M. (Contributor), de Beer, J. (Contributor), Akkerman, O. (Contributor), Peter, S. (Contributor), Ramette, A. (Contributor), Merker, M. (Contributor), Niemann, S. (Contributor), Couto, N. (Contributor), Sinha, B. (Contributor) & Rossen, J. (Contributor), figshare Academic Research System, 24-Nov-2021
DOI: 10.6084/m9.figshare.17075987.v1
Dataset
-
Evaluation of whole-genome sequence data analysis approaches for short- and long-read sequencing of Mycobacterium tuberculosis
Peker, N. (Creator), Schuele, L. (Creator), Kok, N. (Creator), Terrazos, M. (Creator), Neuenschwander, S. M. (Creator), De Beer, J. (Contributor), Akkerman, O. (Creator), Peter, S. (Creator), Ramette, A. (Creator), Merker, M. (Creator), Niemann, S. (Creator), Couto, N. (Creator), Sinha, B. (Creator) & Rossen, J. W. A. (Contributor), Microbiology Society, 2021
DOI: 10.6084/m9.figshare.17075987, https://microbiology.figshare.com/articles/dataset/Evaluation_of_whole-genome_sequence_data_analysis_approaches_for_short-_and_long-read_sequencing_of_Mycobacterium_tuberculosis/17075987
Dataset
Press/Media
-
Using Fingerprints to Detect Antibiotics
27/12/2024
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
My congress 2024 video: Respiratory infections highlights
10/09/2024
1 item of Media coverage
Press/Media: Public Engagement Activities › Popular
-
Aletta Talks. “Air pollution: out and inside”
08/07/2024
1 item of Media coverage
Press/Media: Research › Popular
-
Fingerprints shall predict regularity of TB patients on antitubercular drugs in future, says study
05/07/2024
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
Using a fingerprint for non-invasive drug monitoring
05/07/2024
1 Media contribution
Press/Media: Expert Comment › Popular
Prizes
-
Development of Inhaled Dry Powder Isoniazid: €50,000.00
Akkerman, O. (Recipient), 28-Jun-2021
Prize: Other distinction › Academic
-